TY  - JOUR
AU  - Cobo-Dols, Manuel
AU  - Beato-Zambrano, Carmen
AU  - Cabezon-Gutierrez, Luis
AU  - Chicas-Sett, Rodolfo
AU  - Blancas-Lopez-Barajas, Maria Isabel
AU  - Garcia-Navalon, Francisco
AU  - Firvida-Perez, Jose Luis
AU  - Serrano-Bermudez, Gala
AU  - Togores-Torres, Pilar
AU  - Delgado-Mingorance, Ignacio
AU  - Giraldo-Marin, Alexandra
AU  - Libran-Oriol, Anna
AU  - Paredes-Lario, Alfredo
AU  - Sanchez-Mauriño, Pedro
AU  - Higuera-Gomez, Oliver
AU  - Moreno-Muñoz, Diana
AU  - Jimenez-Lopez, Antonio Javier
AU  - Huerta-Gonzalez, Ibone
AU  - Sanz-Yague, Almudena
AU  - Soler-Lopez, Begoña
PY  - 2020
DO  - 10.1136/bmjspcare-2020-002249
UR  - http://hdl.handle.net/10668/15521
T2  - BMJ supportive & palliative care
AB  - Opioid-induced constipation (OIC) can affect up to 63% of all patients with cancer. The objectives of this study were to assess quality of life as well as efficacy and safety of naloxegol, in patients with cancer with OIC. An observational study was...
LA  - en
PB  - BMJ Group
KW  - Cancer
KW  - Constipation
KW  - Pain
KW  - Quality of life
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Analgesics, Opioid
KW  - Cancer Pain
KW  - Cohort Studies
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Morphinans
KW  - Narcotic Antagonists
KW  - Opioid-Induced Constipation
KW  - Pain Management
KW  - Patient Reported Outcome Measures
KW  - Polyethylene Glycols
KW  - Quality of Life
KW  - Surveys and Questionnaires
TI  - Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis.
TY  - research article
VL  - 11
ER  -